Office of the Vice President for Research


CytoVeris logo

CytoVeris has been founded with the vision to fill an unmet need for innovative new tools that enable surgical oncologists to ‘ID’ and remove all tumor tissue in real-time during cancer resection surgical procedures. These tools will significantly improve surgical outcomes and reduce healthcare costs by minimizing the need for repeat surgeries, as in 20 to 30% of cases, post-operative pathology confirms that the tumor was not removed with clean margins. 

CytoVeris’ solution, the Tumor Margin Assessment Probe (TumorMAP) is based on multimodality optical analysis of tissue, and will allow surgeons the ability to  attain real-time assessment of tumor-to-normal tissue boundaries, thereby improving the surgeon’s ability to ensure clean margins are attained.

Contact: Alan Kersey,